Searched for
ENCUBE ETHICALS VALUATION
Quadria, PE funds eye stake in Samarth Lifesciences; deal may value firm at Rs 4,500 croreQuadria Capital is eyeing a strategic acquisition of a majority interest in Samarth Lifesciences, a move that could value the transaction a...
Encube Ethicals stake sale on hold, IPO likely by 2027Global private equity firms including Warburg Pincus, EQT, and Partners Group had shown interest in acquiring the business at $1.5-1.6 bill...
Warburg Pincus talks in final lap to buy Integrace Health for Rs 1,200 croreIntegrace is currently owned by homegrown PE fund True North and Singapore sovereign investor Temasek Holdings. True North Fund VI LLP hold...
Warburg-Mubadala team up, emerge as frontrunner for EncubeThe consortium is competing against EQT. Mumbai-based pharma co likely to be valued at $1.8 bn. Binding bids are scheduled for next week.
Quadria Capital weighs Encube sale, keeps public float option alive, tooQuadria Capital is exploring options to sell its stake in Encube Ethicals. The healthcare investor considers both a controlling stake sale ...
Quadria Capital to pick up minority stake in drug company AragenQuadria Capital is set to acquire a 10% stake in Aragen Life Sciences for about $100 million, valuing the Indian CRDMO at $1.2 billion. The...
How big is too big?We take a closer look into how the United States and India view and treat Big Tech companies.
What’s behind the insurtech boom?In today's ETtech Morning Dispatch: Acko raises $200 million to become India's latest startup unicorn, Govt-Twitter spat set up escalate ov...
Encube Ethicals gets funding from Quadria Capital, others at $800 million valuationEncube Ethicals’ funding round, that saw participation of Quadria Capital and Gulf Islamic Investments, provides an exit to early backer Re...
Multiples PE looks to exit Encube Ethicals at a valuation of $800 millionEncube Ethicals' promoter Mehul Shah will also sell about 5-10% stake in the company. A clutch of private equity funds, including Carlyle, ...